Tower Research Capital LLC (Trc) Cv Rx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,729 shares of CVRX stock, worth $15,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,729
Previous 3,256
46.9%
Holding current value
$15,733
Previous $19,000
31.58%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CVRX
# of Institutions
96Shares Held
14.3MCall Options Held
59.5KPut Options Held
30.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$37.3 Million7.51% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$18.4 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$9.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.97 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL696KShares$6.34 Million0.01% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $187M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...